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Introduction 
The PRAE (Platform for Research and Applications with Electrons) facility [1] under 
construction in the Orsay campus of the Paris-Sud University, is a multidisciplinary platform 
based on a high-performance new generation linear accelerator delivering a pulsed electron 
beam in the energy range 30-70 MeV, upgradable to 140 MeV. This project originates from 
the complementary expertise of several local scientific research communities involved in 
radiobiology, subatomic physics, instrumentation and particle accelerator technologies to 
perform multidisciplinary studies of significant impact. The 50 MeV to 140 MeV electron 
energy range will be suitable to perform a series of new promising feasibility and 
radiobiological studies of less destructive radiotherapy treatments relying on space 
fractionated sub-millimetric pencil beams and other novel techniques. In the field of 
subatomic physics, we are aiming at a significant contribution to the worldwide effort of 
understanding the puzzle of the proton charge radius [2]. The ProRad experiment will 
investigate electron proton elastic scattering to accurately measure the proton electric form 
factor in an unexplored ultra-low four-momentum squared range. Additionally, a fully 
equipped instrumentation platform will provide the tools to develop a next generation of 
detectors used in many research areas such as medical imaging, subatomic and particle 
physics, spatial technology and astrophysics. With first beam expected by 2021, the PRAE 
facility will provide a unique platform available for academic and non-academic communities 
as well as for the development of outreach programs intended for students. 
Accelerator technology 
The PRAE accelerator is a high-performance electron accelerator [3] consisting of a photo-
injector, an accelerating section and two beamlines (Fig. 1). A photo-injector using current 
technology laser will extract the electrons from the photocathode of a radiofrequency (RF) 
gun. To obtain a high charge per bunch, a metallic magnesium photocathode will be used 
with a laser pulse energy of a few tens of J at a wavelength of 260 nm. The RF gun is made 
of 2.5 copper cells, magnetically coupled to a waveguide. Small emittance is obtained by 
coupling the photocathode with an accelerating field of 80 MV/m, representing a RF power 
of 5 MW in a 3 s pulse. An instrumented section for beam characterization immediately 
follows. The PRAE acceleration section is a 3.5 m long High-Gradient (HG) RF S-band (3 GHz) 
Travelling Wave structure, constituting a compact machine. The final HG structure will 
provide an energy gain of around 65 MeV for an input peak power of 40 MW. The design 
performance of the PRAE beam at the end of acceleration is summarized in Table 1. The 
accelerating section is followed by a 3.5 m drift, that will host a second accelerating 
structure in a second phase. The main beamline separates further into direct and deviated 
lines. The direct line comprises an energy compression system consisting of a magnetic D-
type chicane, involving a movable horizontal collimator, coupled with a dechirping structure 
for reducing the beam energy spread to the few 10-4 required for ProRad operation. The 
deviated line comprises several magnetic elements to cope with the different beams 
scenarii: electron focusing, mini-beams grid… 
 
Figure 1: Infrastructure and implantation of the PRAE accelerator. 
Energy (MeV) 30-70 (140) Repetition rate (Hz) 50 
RF frequency (GHz) 3.0 Bunch charge (nC) 0.00005-2 
Normalized emittance (mm.mrad) 3-10 Bunch number (/pulse) 1 
Energy spread (%) < 0.2 Bunch length (ps) < 10 
 
Table 1: Design performances of the PRAE beam at the end of the accelerating section. 
Radiobiology 
Radiation therapy (RT) is one of the major cancer treatment techniques. It aims at delivering 
a sufficiently high radiation dose to the tumor in order to control the cancer’s progression, 
without causing severe complications to the surrounding healthy organs. However, despite 
the huge advances in dose-delivery modalities and image-guided RT techniques, some 
radioresistant cancers cannot be cured, mainly because of the limited dose that can be 
tolerated by the normal tissues. Most of the RT treatments for superficial tumors are 
currently delivered using mega-volt photon beams or electron beams with energies smaller 
than 20 MeV. Light ion beam therapy (proton, carbon) is a major breakthrough of recent 
decades for the improvement of the treatment efficiency, as it allows, among other 
advantages, the complete tissue sparing after the Bragg peak. Unfortunately, the large cost 
and size of such facilities limit the number of patients that can benefit.  
Very high-energy electrons (VHEE: 70-300 MeV) have gained interest for their use in therapy 
with the improvement of compact accelerator techniques [4], appearing as a potential cost-
effective alternative between photons and protons. Among their major advantages over 
photons, one can retain the possibility to scan small pencil beams, producing a finer 
resolution of intensity modulated treatment, and favorable dosimetric characteristics (low 
lateral penumbrae and reduced sensitivity to tissue heterogeneities) leading to superior 
dose distributions for most clinical cases [5]. Another approach to increase the therapeutic 
window for cancer treatment is to protect the normal tissues by using the concept of 
Spatially Fractionated Radiotherapy (SFR). In SFR, the resulting dose profiles consist of a 
pattern of peaks and valleys, with high doses along the beam paths and low doses in the 
spaces between them. This have been proven safe and effective in delivering large 
cumulative doses without causing severe damage to healthy tissues, either with the GRID 
irradiation technique [6] (centimeter-sized collimated beams) or using mini-beams [7] (beam 
sizes from 400-700 µm). Small beams allow exploiting the dose-volume effects: the smaller 
the beam size, the higher the tolerances of the normal tissue. 
 
 
Figure 2: Principle of the spatial fractionation of dose and VHEE GRID therapy with two examples of peak and valley dose profiles. 
The combination of VHEE with the benefits of GRID therapy has been recently proposed [8]. 
One advantage of using charged beams is that sub-millimetric beam sizes can be obtained 
with pure magnetic collimation, avoiding the degradation of the grid pattern on the 
cumulated dose due to secondary particles coming from a collimator. Varying physical 
parameters such as beam energies, grid sizes and grid spacing, it is possible to favor tumor 
exposure by delivering a quasi-homogeneous dose in the tumor, or to enhance the normal 
tissue tolerance by enlarging the fractionated dose area. Figure 2 illustrates the basic 
principle of VHEE grid therapy, with examples of peaks and valleys dose profiles in depth. 
The first objective of the radiobiology project at PRAE is to implement this fully innovative 
approach on the PRAE deviated beamline in order to evaluate its therapeutic benefit in 
sparing normal tissues. The high-performance of the beam is a key point of the success of 
this investigation which requires sub-millimetric beam sizes, small beam divergence, high 
energies, high stability and reproducibility. First theoretical studies demonstrated the 
feasibility of such an implementation at PRAE [9]. Preliminary experimental dosimetry 
measurements will validate the technique and motivate preclinical studies. 
Beyond the demonstration that a compact, performant and cost-effective machine can be 
constructed, the PRAE facility intends in a second phase to provide beam for biological 
experiments (in vitro and in vivo) to deepen the knowledge on VHEE therapy. 
 
The ProRad experiment 
 
Figure 3: The 
Q2 coverage of 
the worldwide 
low-Q2 
experimental 
effort 
compared to 
existing data 
on the proton 
electric form 
factor. 
The ProRad (Proton Radius) experiment aims at providing new high accuracy data in an 
unexplored ultra-low four-momentum transfer (Q2) domain, to help understand the still 
present proton charge radius puzzle [2,10]. After about a decade and several new 
measurements, the difference between muonic hydrogen spectroscopy [11] and elastic 
electron scattering [12] measurements of the charge radius of the proton (Rp) is not yet 
understood. An unprecedented low-Q2 experimental effort (Fig. 3) is developing worldwide 
to assess Rp as measured from the scattering technique. Part of the problem comes from the 
fact that the subatomic method does not provide a direct measurement, but accesses Rp 
through the zero-extrapolation of the Q2-slope of the electric form factor of the proton. 
Forthcoming data at low-Q2 are expected to provide a better measurement of Rp by firmly 
controlling the extrapolation procedure. 
As many experiments in this Q2-range, ProRad is facing several challenges to be able to reach 
significant precision. ProRad is designed to provide 0.1% accurate measurements of the ratio 
of the cross sections between elastic and Møller electron scatterings. The setup follows 
simple and robust considerations for particle identification, position, and energy 
measurements in a non-magnetic environment at energies well below the pion production 
threshold. The reaction chamber hosts a windowless target made of a 15 m diameter solid 
hydrogen jet [13], effectively concretizing a pure and nearly point-like target. A 2 m long 
vacuum vessel is closed by an end-cap which supports the detector elements. They consist of 
28 elementary cells organized symmetrically around the beam and located at different 
scattering angles. The elementary cell is composed of two layers of thin scintillator strips 
followed by a cylindrical BGO crystal. The scintillator hodoscope acts all at once as a neutral 
particle discriminator, a charged particle tagger, and a position detector which defines the 
electron scattering angle. The same BGO crystal simultaneously measures elastic and Møller 
electrons which are distinguished at each scattering angle by their different energies. 
The dominant sources of ProRad systematic uncertainties originate from the knowledge of 
the absolute incident electron beam energy (E0) and the scattered electron angles. To 
achieve the necessary precision on E0 (5x10-4), the ProRad beamline will feature a magnetic 
dipolar deviation where the beam deviation angle and the field integral along the beam 
trajectory will be accurately measured. Thanks to the PRAE beam properties and the quasi-
point-like nature of the target, the positioning of the hodoscope is the main source of angle 
systematics. With a position accuracy better than 100 m ProRad will achieve 0.05 mrad 
systematical error on the scattering angle. Altogether, ProRad is an experimental challenge 
at the precision frontier. 
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